clinical
Hidden MS Data Exposes $2B Pipeline Wasted
Real-world data (RWD) shows that pharmaceutical firms are overlooking treatment failures in multiple sclerosis, costing the industry roughly $2 billion in wasted pipeline spend. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions. The